Table of Contents

Methadone (Methadose)

Primer

Methadone (Trade name: Methadose) is a synthetic mu-opioid agonist, similar to morphine. Methadone is used in the treatment opioid use disorder, but prolonged use of methadone itself can also result in dependence.

Pharmacokinetics

Pharmacokinetics of Methadone

Absorption Well absorbed following oral administration. The bioavailability of methadone ranges between 36 to 100%.
Distribution 1 to 8 L (mostly in plasma and blood)
Metabolism Hepatic, via cytochrome P450 enzymes
Elimination Excreted mainly in the urine
Half-life 25 hours

Methadone: Cytochrome P450 Metabolism

Substrate of (Metabolized by) 3A4, 2B6, and 2C19
(lesser extent by CYP2C9 and CYP2D6)
Induces -
Inhibits -

Pharmacodynamics

Mechanism of Action

Toxicity

Indications

Suboxone or Methadone?

Suboxone (buprenorphine/naloxone) has the following advantages over methadone:

Dosing

Dosing for Methadone

Starting
Titration
Maximum
Taper

Formulations

Monitoring

Contraindications

Absolute

Avoid Prescribing Benzodiazepines!

The concomitant use of opioids with benzodiazepines or other central nervous system depressants such as alcohol can cause profound sedation, respiratory depression, coma, and even death.

Relative

Drug-Drug Interactions

Methadone is also a Serotonin Reuptake Inhibitor!

Although it is classified as an opioid, many people forget that methadone is also a serotonin re-uptake inhibitor that specifically inhibits serotonin transporter (SERT). This means it can cause serotonin syndrome if co-prescribed with other serotonergic medications!

Side Effects

Adverse Events

Clinical Pearls

Special Populations

Geriatric

Pediatric

Obstetric and Fetal

Medically Ill

Guidelines

Opioid Use Disorder Guidelines

Guideline Location Year PDF Website
Canadian Medical Association Journal (CMAJ) Canada 2018 - Link
BC Centre on Substance Use (BCCSU) Canada 2023 Link Link
META:PHI Canada 2019 Link Link
Canadian Guidelines on Opioid Use Disorder Among Older Adults Canada 2020 PDF Link
National Institute for Health and Care Excellence (NICE) UK 2007 - Link
American Psychiatric Association USA 2006, 2007 - Guideline (2006)
Guideline Watch (2007)
Quick Reference

Resources